Stock listing

A2PLR5 Stock Price, News, Filings & Events — Adaptive Biotechnologies Corporation

Selected listing: A2PLR5 · LS · EUR · DE

The selected listing A2PLR5:LS represents Adaptive Biotechnologies Corporation. The company focuses on leveraging its proprietary immune profiling technology to develop diagnostics and therapeutics for various diseases, including cancer and autoimmune disorders. Recent news highlights their ongoing collaborations and advancements in clinical trials, which aim to enhance patient outcomes. Investors can stay updated on the latest filings and events that may impact the company's market position and growth potential.

A2PLR5:LSEURDEUpdated July 24, 2026
Adaptive Biotechnologies Corporation logo
Ticker
A2PLR5:LS
Asset type
Stock
Market cap
$3.56B
Sector
Health Technology
Industry
Biotechnology
Exchange
LS
Currency
EUR

Adaptive Biotechnologies Corporation A2PLR5:LS stock context

The selected listing A2PLR5:LS represents Adaptive Biotechnologies Corporation. The company focuses on leveraging its proprietary immune profiling technology to develop diagnostics and therapeutics for various diseases, including cancer and autoimmune disorders. Recent news highlights their ongoing collaborations and advancements in clinical trials, which aim to enhance patient outcomes. Investors can stay updated on the latest filings and events that may impact the company's market position and growth potential.

Research Adaptive Biotechnologies Corporation

Alternate listings